A meeting with Covid-19 survivors

First Arizona patient on ventilator survives COVID-19 with rare blood treatment - April 15, 2020 PHOENIX – A Phoenix man is the first in Arizona to survive COVID-19 through a rare form of treatment called extracorporeal membrane oxygenation (ECMO) therapy. Enes Dedic, 53, was on the brink of death with a ventilator until his doctors at HonorHealth used ECMO as a last resort. Dedic is among the first U.S. COVID-19 patients to survive the disease by using the treatment and is among around 10 worldwide. ECMO works by helping oxygenate blood outside the body so blood doesn't need to transfer through damaged or filled lungs. Instead, tubes carry blood from the body to an external artificial lung that removes carbon dioxide and adds oxygen, at which point an artificial heart pumps the blood back into the body. https://www.yahoo.com/news/first-arizona-patient-ventilator-survives-104531736.html

Since red blood cells carry oxygen, and since malaria is a disease that effects red blood cells, and HQ is used to treat malaria, then this fits in with the fact that HQ has been shown to be effective as a therapeutic for Covid-19: Further notes:

China’s cases of Covid-19 are finally declining. A WHO expert explains why. Excerpt: Second thing they do is ventilate dozens in the average hospital; they use extracorporeal membrane oxygenation [removing blood from a person’s body and oxygenating their red blood cells] when ventilation doesn’t work. This is sophisticated health care. They have a survival rate for this disease I would not extrapolate to the rest of the world. What you’ve seen in Italy and Iran is that a lot of people are dying. This suggests the Chinese are really good at keeping people alive with this disease, and just because it’s 1 percent in the general population outside of Wuhan doesn’t mean it [will be the same in other countries]. https://www.vox.com/2020/3/2/21161067/coronavirus-covid19-china COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism - 27.03.2020 https://chemrxiv.org/articles/COVID-19_Disease_ORF8_and_Surface_Glycoprotein_Inhibit_Heme_Metabolism_by_Binding_to_Porphyrin/11938173/5 Covid-19 had us all fooled, but now we might have finally found its secret. Excerpt: The core point being, treating patients with the iron ions stripped from their hemoglobin (rendering it abnormally nonfunctional) with ventilator intubation is futile, unless you’re just hoping the patient’s immune system will work its magic in time. The root of the illness needs to be addressed. Best case scenario? Treatment regimen early, before symptoms progress too far. Hydroxychloroquine (more on that in a minute, I promise) with Azithromicin has shown fantastic, albeit critics keep mentioning ‘anecdotal’ to describe the mountain, promise and I’ll explain why it does so well next. But forget straight-up plasma with antibodies, that might work early but if the patient is too far gone they’ll need more. They’ll need all the blood: antibodies and red blood cells. No help in sending over a detachment of ammunition to a soldier already unconscious and bleeding out on the battlefield, you need to send that ammo along with some hemoglobin-stimulant-magic so that he can wake up and fire those shots at the enemy. http://web.archive.org/web/20200405061401/https://medium.com/@agaiziunas/covid-19-had-us-all-fooled-but-now-we-might-have-finally-found-its-secret-91182386efcb Antimalarial Drugs as COVID-19 Therapy: On chloroquine and hydroxychloroquine. - J. Scott Turner - Professor of Biology at the State University of New York College https://inference-review.com/report/antimalarial-drugs-as-covid-19-therapy

bornagain77

BA77, excellent finds. A breath of fresh air. KF kairosfocus

Of related note: Inference magazine has a special issue on Covid-19

SPECIAL REPORTS / SARS-COV-2 AND COVID-19 https://inference-review.com/articles/special-reports/ SARS-CoV-2 and COVID-19 Antimalarial Drugs as COVID-19 Therapy by J. Scott Turner On chloroquine and hydroxychloroquine. ( APRIL 10, 2020 ) An End to Globalization by Michael O'Sullivan Friction and volatility in a multipolar world. ( APRIL 10, 2020 ) Enter the Coronavirus by Henri Lepage On the pandemic and a looming global recession. ( APRIL 10, 2020 ) History and Risk by Vaclav Smil Historical perspectives and risk assessments. ( APRIL 3, 2020 ) The Cell Biology of SARS-CoV-2 by Anthony Futerman On the characteristic biological features. ( APRIL 3, 2020 ) COVID-19 and the Global Economy by John Feffer Fundamental changes are afoot. ( APRIL 3, 2020 ) Therapeutic Options for COVID-19 by John Hewitt A critical analysis of the currently available options. ( APRIL 3, 2020 ) SARS-CoV-2: Research Guide by The Editors 52 articles, updated April 3, 2020.

bornagain77

A meeting with Covid-19 survivors . . . hear their voices (don't mind the interviewer). kairosfocus